FDA Inspection 702633 — Morton Grove Pharmaceuticals, Inc.

Morton Grove Pharmaceuticals, Inc. — FEI 1420913

The FDA completed an inspection of Morton Grove Pharmaceuticals, Inc. on April 12, 2011 in Morton Grove, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 12, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Morton Grove, IL (United States)

Citations

IDCFRDescription
135821 CFR 211.100(b)SOPs not followed / documented
202721 CFR 211.192Investigations of discrepancies, failures
357021 CFR 211.100(a)Approval and review of procedures
438921 CFR 211.198(a)Procedures to be written and followed